Know Your Patient: How Technology Can Help Health Care Providers Dramatically Improve One Key Aspect of the Patient Experience
Digitization has certainly cut down on the paperwork glut in healthcare. But if that’s the…
Know Your Patient: How Technology Can Help Health Care Providers Dramatically Improve One Key Aspect of the Patient Experience
Digitization has certainly cut down on the paperwork glut in healthcare. But if that’s the extent of technology’s impact on the patient experience, it’s clearly not enough. The post Know Your Patient: How Technology Can Help Health Care Providers Dramatically Improve One Key Aspect of the Patient Experience appeared first on MedCity News.
Healthcare’s Most Fixable Cost Problem: Administrative Waste
The good news: fixing our ancient administrative infrastructure does not require technology that’s particularly experimental, nor does it require passing new laws or regulations. It does, however, require coordination. The post Healthcare’s Most Fixable Cost Problem: Administrative Waste appeared first on MedCity News.
Watch: As AI Makes More Health Coverage Decisions, the Risks to Patients Grow
This year, executives from nearly every major health insurance company made the same declaration in calls with Wall Street analysts: Using artificial intelligence to make coverage decisions would help save them money. Even the Trump administration is testing AI’s usefulness in managing the prior authorization process for the Medicare program, as well as seeking to…
For Many Patients Leaving the ICU, the Struggle Has Only Just Begun
The accident happened in Pittsburgh on Nov. 16. Joseph Masterson, a lawyer who was just days from retiring at age 63, suffered cardiac arrest while driving, plowed into a guardrail, and lost consciousness. Other drivers stopped, broke the car window, and pulled him to safety. A passing volunteer firefighter performed CPR until an ambulance arrived…
Quantifying the Rural Access Problem: Emergency Cardiac Care as a Window into American Healthcare
By ANISH KOKA I was listening to a conversation between two critical thinkers I respect greatly: geneticist/technologist/blogger Razib Khan and Washington Post columnist Megan McArdle. Their discussion was a freewheeling rant about the problems they see with the rise of populism on the left and right, but a throwaway comment related to the US physician shortage in the…
Luminai Raises $38M With Cleveland Clinic Using Its AI for Hospital Operations
Luminai raised $38 million in Series B funding to scale its AI platform that automates healthcare administrative workflows. The company is working with Cleveland Clinic to expand the use of its system across high-volume processes, starting with referral management. The post Luminai Raises $38M With Cleveland Clinic Using Its AI for Hospital Operations appeared first…
Quantifying the Lifetime Economic Impact of Pediatric Oral Nutritional Supplements
That is the title of a new paper published this week in Clinical Nutrition with co-authors Kyi-Sin Than, Khounish Sharma, Kirk W. Kerr, and Dhanasekhar Kesavelu. The abstract is below: IntroductionPediatric malnutrition is a significant global public health challenge, particularly in low- and middle-income countries. This study quantifies the lifetime, per-person economic impact of pediatric…
Which Health Plans Rank Highest In Digital Experience?
Cigna Healthcare ranks highest in digital experience among commercial plans, while UPMC Health Plan ranks highest among Medicare Advantage plans, according to a new JD Power report. The post Which Health Plans Rank Highest In Digital Experience? appeared first on MedCity News.
7th and possibly final update on the $39.94 lab test bill
By MATTHEW HOLT I know you all care, so I am giving a 7th update on the telenovela about my Labcorp bill for $34.95. The very TL:DR summary of where we are so far is that in May 2025 I had a lab test to go with the free preventative visit that the ACA guarantees, but I…
Gilead and Roche Bet on Protein Degraders for Their Cancer Drug Pipelines
Gilead Sciences exercised its option license a Kymera Therapeutics’ protein-degrading drug designed to eliminate the cancer-driving protein CDK2. Meanwhile, Roche’s new partnership with C4 Therapeutics is focused on developing degrader antibody drug conjugates for undisclosed cancer targets. The post Gilead and Roche Bet on Protein Degraders for Their Cancer Drug Pipelines appeared first on MedCity…
